resulting in approximately 28,000 cases (Musso, Nilles, and Cao-Lormeau 2014) . From there, the virus cropped up in the Cook Islands, Easter Island, New Caledonia, the Solomon Islands, and other Pacific islands (Musso 2015) .
Current Outbreak in the Americas
In late 2014, the Zika virus first emerged in Brazil (Kleber de Oliveira et al. 2016) , presumably stemming from the 2014 Va'a World Sprint Championship canoe race held in Rio de Janeiro, which reportedly included participants from ZIKV infected areas of French Polynesia (Musso 2015, Gautret and Simon 2016) . Finding abundant breeding grounds for its mosquito vector in the densely populated urban environments of Brazil, and an immunologically naïve host population, the virus was able to spread rapidly northward and westward over the course of the next year, reaching Mexico by November 2015 (Gatherer and Kohl 2016) , Puerto Rico by December 2015 (Thomas et al. 2016) , and threatening to reach continental United States in 2016.
As number had jumped to 312; and two months later, 472 cases had been reported, all of which were travel-associated. As of May 04, 2016, no autochthonous mosquito-borne cases of ZIKV had been documented in the United States. However, in the US territories, the situation was quite the reverse. As of May 04, 2016, 661 cases were reported in American Samoa, Puerto Rico, and the US Virgin Islands, including 3 (0.5%) travel-associated cases and 658 (99.5%) autochthonous cases, of which 629 (95.6%) occurred in Puerto Rico (Centers for Disease Control and Prevention 2016). The most up to date epidemiological information on the Zika virus outbreak in the Americas can be found by consulting the resources listed in Table 1 .
<Insert Table 1 Adaptive changes made by the Zika virus making it more pathogenic or better able to be transmitted by new arthropod vectors may also be contributing factors (Costa et al. 2016 ).
Virology
The Zika Virus (ZIKV) is an arthropod-borne virus ("arbovirus") of the family Flaviviridae, genus Flavivirus, a group of positive-sense, single-stranded RNA (+ssRNA) viruses that includes the dengue, yellow fever, West Nile, and the Japanese encephalitis viruses. Table 2 here> Upon injection of the virus into the skin of the human host, a complicated sequence of events occurs at the molecular level, leading to attachment and entry of the virus into target cells, and ultimately hijacking of the host's cellular machinery by the virus for its own replication.
Consistent with its primary mode of transmission, human dermal fibroblasts, epidermal keratinocytes, and dendritic cells in the skin have been shown to be highly permissive to infection with ZIKV; additionally, the virus has been found to induce the production of autophagosomes in infected fibroblasts, possibly as a means of promoting viral replication (Hamel et al. 2015) . After replication in skin cells, the virus disseminates via the lymphatics and blood stream to other parts of the body, including the CNS, heart, skeletal muscles, and possibly crossing the placenta to reach the developing fetus (Chan et al. 2016) . The exact target cells of ZIKV are not yet known, though various studies suggest neurological cells may be chief among them. A 1952 study in mice showed the Zika virus to be highly neurotropic (Dick 1952) ; an in vitro model indicated that human cortical neural progenitors are readily infected by ZIKV (Tang et al. 2016) ; and an in vitro model mimicking brain development in the first trimester demonstrated that ZIKV induces cell death in cultured neural stem cells (Garcez et al. 2016 ). (Zanluca et al. 2015 , Musso 2015 .
Arthropod-borne Transmission
The principal mode of transmission of ZIKV to humans is through the bite of an infected mosquito. The arthropod vector most frequently implicated in the transmission of ZIKV is the female Aedes aegypti mosquito, which also transmits dengue, yellow fever, and chikungunya.
The Aedes aegypti mosquito secured its place in the annals of history when, at the turn of the 20 th century, it became the object of intense research by Dr. Carlos Juan Finlay, Dr. Jesse William Lazear, Major Walter Reed, and others in their heroic efforts to conquer yellow fever.
The Aedes aegypti mosquito is notable in that it feeds throughout the day, prefers humans as the source of its blood meals, and feeds both indoors and outdoors. Over the millennia, this species of mosquito has adapted to coexist with humans, developing a predilection for breeding in small pools of stagnant water such as those found in artificial containers in and around areas of human habitation (Fauci and Morens 2016 Asia, ZIKV is believed to be maintained in a sylvatic cycle between mosquito and non-human primates, probably monkeys (Lazear and Diamond 2016, Zanluca and Duarte Dos Santos 2016) .
Antibodies to the virus have been detected in various large mammals and rodents, but it is not known whether these animals serve as reservoirs (Zanluca and Duarte Dos Santos 2016) .
In the United States, the geographic range of Aedes aegypti extends into the southeastern part of the country, making it feasible that vector-borne autochthonous cases will occur in states such as Florida, Texas, and Louisiana. However, ZIKV is also transmitted by several other Aedes species, including Aedes albopictus (Chouin-Carneiro et al. 2016) , which notably has a more northerly geographic range that extends well into the central and eastern part of the country (Kraemer et al. 2015) .
If the ZIKV genome is able to make adaptive changes to improve the effectiveness of the A. albopictus mosquito as a vector, as occurred with the chikungunya virus, it could move into areas lacking A. aegypti, potentially bringing the virus to much of the US, as well as to Canada, Chile, and parts of Europe and Asia (Gardner, Chen, and Sarkar 2016 , Stein 2016 , Petersen and Busch 2010 . The virus has been recovered from other mosquito genera as well, such as Anopholes, Culex, and Mansonia (Ayres 2016) , though again it is not clear whether they are able to serve as competent vectors (Gardner, Chen, and Sarkar 2016) .
Non-arthropod-borne Transmission
The potential for vertical transmission from mother to child emerged as a major global health concern in the 2015-2016 outbreak due to the observed increase in microcephaly in fetuses/newborns of mothers who had been infected with ZIKV during pregnancy (Kleber de Oliveira et al. 2016) . Microcephaly has been traditionally defined as an abnormally small head that is more than 2 standard deviations (SDs) below the mean for the age and sex of the child (Weaver 1999) . In Brazil, the national live birth registry applied a stricter definition for microcephaly as being >= 3 SDs for age and sex (Kleber de Oliveira et al. 2016 ).
Temporal and circumstantial evidence has been reported for the transplacental transmission of ZIKV and its association with microcephaly. Amniotic fluid from two pregnant women in Brazil with past exposure to ZIKV who were diagnosed with fetal microcephaly was shown to be positive for the Zika virus (Oliveira Melo et al. 2016) , and autopsy results of a microcephalic fetus of a woman who was presumed to have had a ZIKV infection at 13 weeks' gestation showed ZIKV in the brain tissues (Mlakar et al. 2016) .
The mechanisms by which ZIKV may cause microcephaly and other neurological defects
are not yet clear. The virus could cross the placental barrier and infect the fetus directly, as occurs with rubella and cytomegalovirus (Mor 2016) . Alternatively, the virus may induce an inflammatory response in the placenta, or it may disrupt the production by the placenta of particular genes, molecules, or pathways, which in turn may adversely affect fetal brain development (Adibi et al. 2016 , Mor 2016 ).
Sexual transmission has been confirmed in a small number of cases in the US and elsewhere as a result of sexual contact with men returning from travel to Zika-infected areas who experienced symptoms consistent with ZIKV Infection (Foy et al. 2011 , McCarthy 2016 , Oster et al. 2016 . The semen of a man who contracted a ZIKV infection in the 2013-2014 French Polynesia outbreak tested positive for the virus on reverse transcriptase polymerase chain reaction (RT-PCR) two weeks after recovering from the illness . In a 2014 travel-associated case in the United Kingdom, semen from a man tested positive for ZIKV at 27 and 62 days after onset of illness (Atkinson 2016) . Both cases raise concerns Other possible routes of transmission, such as saliva, urine, respiratory droplets, breast milk, vaginal delivery, mucocutaneous exposure, hemodialysis, and organ transplantation, cannot be ruled out (Chan et al. 2016 ).
Transmission of ZIKV through blood transfusion is a credible risk, given the asymptomatic viremia that occurs early in the infection, the high rate of asymptomatic cases, and the high incidence of infection that occurs among immunologically naïve populations during massive outbreaks (Marano et al. 2015, Petersen and Busch 2010) . In the 2013-2014 outbreak in French Polynesia, 2.8% (42/1505) of asymptomatic blood donors tested positive for ZIKV on RT-PCR, and 26.2% (11/42) of those reported a Zika-like illness 3-10 days after donating blood ).
In lieu of a blood donor screening test for ZIKV for use by blood collection centers, the US Food and Drug Administration has issued the following guidelines for blood donations. In areas with no active ZIKV transmission, a 4-week deferral period is recommended for donors deemed to be at risk for Zika infection, and in areas with active transmission, it is recommended that blood and blood products be obtained from outside the region (Marks, Epstein, and Borio 2016) .
However, in geographically isolated areas, it may be impractical or impossible to obtain blood from another region. Such was the case during the 2013-2014 French Polynesia outbreak, prompting local health authorities to grant permission for use of RT-PCR to screen locally donated blood, coupled with pathogen inactivation for selected blood products (Musso et al. 2014). In the future, it is hoped that pathogen reduction techniques will be developed that could be applied to all blood products, thereby reducing the need for the battery of expensive screening tests currently in use (Marks, Epstein, and Borio 2016) .
Zika Virus Infections
In approximately 80% of cases, infection with the Zika virus is asymptomatic or very mild, with only about 20% of those infected actually becoming ill (Centers for Disease Control and Prevention 2016a). Those who become symptomatic, do so following an incubation period of 2-14 days (Chan et al. 2016 , Rudolph et al. 2014 , with a systemic febrile rash illness similar to dengue or chikungunya. The current PAHO/WHO definition for a suspected case of Zika Virus Disease is a patient with rash, plus two or more of the following symptoms: fever, conjunctivitis, arthralgia, myalgia, and peri-articular edema (Pan American Health Organization 2016a). Other symptoms that have been reported include headache, fatigue, malaise, chills, retroorbital pain, paresthesia, lymphadenopathy, edema, diarrhea, nausea, vomiting, abdominal pain, sore throat, dizziness, and dysuria (Brasil et al. 2016 , Chan et al. 2016 ).
Since fever is not always a presenting symptom, use of the term "Zika Fever" is discouraged. In fact, a 2016 report of ZIKV infections in pregnant women in Brazil showed that whereas maculopapular rash, conjunctivitis, and lymphadenopathy were clinically significant features, fever was present in only 28% of the cases (Brasil et al. 2016) . However, other studies showed higher numbers: in a retrospective study of 2015 data from Brazil, 67% of patients had fever (Cerbino-Neto J 2016), and a study from Puerto Rico in 2015-2016 showed that 73% had fever (Thomas et al. 2016 ). 
Complications of Zika Virus Infections
Despite the mild nature of the disease and high rate of asymptomatic cases, Zika virus infections are of concern because of their suspected association with microcephaly and other neurological abnormalities. In the 2013-2014 outbreak in French Polynesia, perinatal transmission, either transplacentally or during delivery, was reported (Besnard et al. 2014) , and a retrospective analysis of the data suggested that exposure to ZIKV by pregnant women in the first trimester was associated with an increased risk of microcephaly (Cauchemez et al. 2016 ). In trimester of pregnancy appear to be associated with an increased risk of microcephaly (Cauchemez et al. 2016 , Kleber de Oliveira et al. 2016 , though fetal abnormalities have been reported following ZIKV infections during any week of gestation (Brasil et al. 2016) . Miranda-Filho et al. 2016) . Zika virus infections during pregnancy were found to be associated with intrauterine growth restriction, cerebral calcifications, placental insufficiency, and oligo-or anhydramnios (Brasil et al. 2016) . In a small study of microcephalic newborns, various ocular defects were found, including optic nerve alterations and macular abnormalities, especially foveal reflex loss (Ventura et al. 2016 ).
In addition to congenital complications, Zika infections have been associated with an Emergency of International Concern (PHEIC) due to concern over the possibility of an association between ZIKV infections and microcephaly, GBS, and other neurological disorders From a societal and sociological standpoint, numerous immediate and long-term repercussions of the current ZIKV outbreak are becoming apparent. Counseling will be required for pregnant women who contract a ZIKV infection, especially during the first trimester.
Intensive care treatment for patients struck by Guillain-Barre Syndrome will be crucial, as will long-term treatment of newborns with microcephaly and other neurological abnormalities.
Patients will need multidisciplinary support and ongoing medical care, incurring a substantial burden to individuals, families, and communities. These factors will have serious long-term implications for overall health policy, especially in resource-poor regions.
Laboratory Diagnosis
Currently, there is no rapid diagnostic test for ZIKV available for routine use in clinical However, urine may prove to be a suitable alternative, as the RNA load in urine has been found to be higher than in serum and is detectable for a longer period of time, and, as a laboratory specimen, it is less invasive to collect (Gourinat et al. 2015) . Saliva may also prove to be a useful substitute or adjunct for acute phase diagnosis, especially in pediatric patients, as it will sometimes test positive for ZIKV when a concurrent serum sample tests negative . In the future, it is hoped that diagnostic tests will be developed that are able to detect multiple arbovirus infections, such as Zika, dengue, and chikungunya, simultaneously (Waggoner and Pinsky 2016) . 
Prevention
Since there is currently no vaccine for ZIKV, prevention of ZIKV infections is primarily focused on averting arthropod-borne transmission of the infectious agent, both through reducing the population of mosquitoes, and reducing contact between mosquitoes and humans (World Health Organization 2016b). At the individual level, the use of protective clothing and an Environmental Protection Agency (EPA)-registered insect repellent, such as DEET, picaridin,
IR3535, oil of lemon eucalyptus, or para-menthane-diol, is recommended (Centers for Disease
Control and Prevention 2016a). For patients who become symptomatic, it is particularly important to avoid mosquito bites during the first week of illness to prevent transmission of the virus to others during the viremic period. Within the household, small pools of standing water in and around the home should be eliminated to reduce mosquito breeding habitat. Water storage receptacles and artificial containers should be emptied or covered, and bathing, cooking, and laundry areas should be kept as dry as possible. Since the Aedes mosquito bites throughout the day, both indoors and out, the installation of securely fitting window and door screens on homes, and the use of bed nets is advised. These measures are especially important for pregnant women, or those who might become pregnant, in order to prevent possible perinatal transmission.
At the community level, aggressive vector control will serve to disrupt the urban transmission cycle between infected humans, the mosquito vector, and susceptible humans.
Efforts should be made to reduce the density of mosquitoes in the locality, and during outbreaks, the spraying of insecticides may be advised (World Health Organization 2016b). Public education campaigns conducted in schools, churches, clinics, stores, and businesses in regions of active transmission will help to raise public awareness of the risks and symptoms of ZIKV infections. Health care professionals are advised to remain alert for signs and symptoms of ZIKV infection among their patients, and whenever possible, provide ultrasound and other diagnostics to pregnant women who may have been exposed. Data and information sharing between communities, and enhanced surveillance at the national and international level, will further contribute to the global prevention and control of widespread ZIKV outbreaks.
In response to studies demonstrating the sexual transmission of ZIKV, the CDC has issued an interim guideline for couples in which a man lives in or has recently traveled to an area of active transmission (Oster et al. 2016) . In addition, the CDC has issued a number of guidelines directed at specific populations, including pregnant women and pregnant travelers, and health care providers caring for pregnant women and infants and children. Since these guidelines are 
Future Perspectives
The two previous large-scale outbreaks of the Zika virus, which occurred in the Yap
Islands in 2007 and French Polynesia in 2013-2014, abated after roughly a year. Though it is too early to determine whether the current outbreak in the Americas will follow the same pattern, it is already clear that this event has exacted a heavy toll on the populations it has affected. In spite of, or perhaps because of, the enormous challenges it has presented, this outbreak has triggered a dramatic increase in our overall understanding of this emerging disease. Indeed, the number of scholarly publications published on the Zika virus has multiplied exponentially in the past year, as the medical and scientific communities struggle to understand this mysterious illness and its sequelae. Yet, there remains much to be learned.
Research initiatives are proceeding apace on multiple fronts, both at the basic science and clinical level, focusing on all aspects of the virus/vector/host triad. The National Science The mosquito vector itself has been, and will continue to be, the subject of active research. Mosquito resistance to insecticides has long been the subject of research in the context of malaria and other arbovirus diseases, and will have clear implications for ZIKV transmission.
Studies on the effect of global climate change on the lifespan and geographic ranges of vector Complementing these initiatives, the National Institute of Allergy and Infectious Diseases (NIAID), has invited proposals for projects covering a wide range of basic science and clinical aspects of ZIKV and Zika Virus Disease (National Institute of Allergy and Infectious Diseases).
( Table 3) <Insert Table 3 here> Though information gained from each of these research foci will be essential for building the overall knowledgebase of Zika, research in three areas in particular is urgently needed. First, it is critically important that the mechanism by which the Zika virus causes congenital neurological abnormalities be elucidated, in order to prevent the development of devastating birth defects. Secondly, an affordable, rapid, and reliable diagnostic test for ZIKV for use in clinical environments is vital to enable the timely and accurate diagnosis of Zika infections.
Finally, the development of a safe and effective vaccine against ZIKV is a clear priority, as it may well prove to be the world's best hope for conquering this new disease. Yet the development of a vaccine for any infectious disease is no trivial matter. At best, it can take years, perhaps decades, to come to fruition. At worst, the efforts will sputter and stall, only to languish as unfunded, orphan initiatives. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 ZIKV genes into bacterial cells, resulting in the production of "virus-like particles" that will elicit an immune response similar to that of inactivated vaccines (Cohen 2016) .
Bypassing the need for a bacterial carrier cell altogether, Inovio Pharmaceuticals of Pennsylvania, USA is working to develop a vaccine using simply a plasmid containing Zika virus genes, which would be injected directly into the skin. Though this method can be used to produce a vaccine relatively quickly, in the past, it has been plagued by failure to launch a sufficiently strong immune response. Still another high-tech strategy is to insert the ZIKV genes into the genome of a harmless virus, which is similar to the approach used by GlaxoSmithKline for its recently developed Ebola vaccine (Cohen 2016) .
Which of these strategies will eventually emerge as the industry leader(s) is anybody's guess at this point. The fervent hope of the general public and health authorities alike is that one of them will ultimately be successful in producing a vaccine capable of forestalling the next Zika pandemic. 
Conclusion
Though once thought of merely as the source of a mild, unremarkable arboviral disease that was little cause for concern, the Zika virus has proven its ability to wreak havoc on a global scale. The medical and scientific community is still very early in the process of understanding the science of this disease and its clinical sequelae, and much of the information presented herein may already be outdated. As this event unfolds, we are witnessing the creation of medical history before our very eyes and observing the generation of scientific knowledge in real time, with new findings being revealed on almost a daily basis. May the lessons learned carry us forward, ready and prepared to meet the next emerging viral pandemic. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 In Jan 2016, the NIAID issued a call for Zika-related research proposals in the following areas:
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